AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
CELLULAR PHARMACODYNAMICS AND PLASMA PHARMACOKINETICS OF PARENTERALLYINFUSED HYDROXYUREA DURING A PHASE-I CLINICAL-TRIAL IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: GANDHI V PLUNKETT W KANTARJIAN H TALPAZ M ROBERTSON LE OBRIEN S
Citation: V. Gandhi et al., CELLULAR PHARMACODYNAMICS AND PLASMA PHARMACOKINETICS OF PARENTERALLYINFUSED HYDROXYUREA DURING A PHASE-I CLINICAL-TRIAL IN CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 16(7), 1998, pp. 2321-2331
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC-LYMPHOCYTIC-LEUKEMIA (CLL) RECEIVING FLUDARABINE REGIMENS AS INITIAL THERAPY
Authors: KEATING MJ OBRIEN S LERNER S KOLLER C BERAN M ROBERTSON LE FREIREICH EJ ESTEY E KANTARJIAN H
Citation: Mj. Keating et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC-LYMPHOCYTIC-LEUKEMIA (CLL) RECEIVING FLUDARABINE REGIMENS AS INITIAL THERAPY, Blood, 92(4), 1998, pp. 1165-1171
2-CHLORODEOXYADENOSINE THERAPY FOR IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
Authors: UENO NT ZHAO S ROBERTSON LE CONSOLI U ANDREEFF M
Citation: Nt. Ueno et al., 2-CHLORODEOXYADENOSINE THERAPY FOR IDIOPATHIC HYPEREOSINOPHILIC SYNDROME, Leukemia, 11(8), 1997, pp. 1386-1390
HODGKINS-DISEASE VARIANT OF RICHTERS-SYNDROME - EXPERIENCE AT A SINGLE INSTITUTION
Authors: FAYAD L ROBERTSON LE OBRIEN S MANNING JT WRIGHT S HAGEMEISTER F CABANILLAS F KEATING MJ
Citation: L. Fayad et al., HODGKINS-DISEASE VARIANT OF RICHTERS-SYNDROME - EXPERIENCE AT A SINGLE INSTITUTION, Leukemia & lymphoma, 23(3-4), 1996, pp. 333-337
BCL-2 EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND ITS CORRELATION WITH THE INDUCTION OF APOPTOSIS AND CLINICAL OUTCOME
Authors: ROBERTSON LE PLUNKETT W MCCONNELL K KEATING MJ MCDONNELL TJ
Citation: Le. Robertson et al., BCL-2 EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND ITS CORRELATION WITH THE INDUCTION OF APOPTOSIS AND CLINICAL OUTCOME, Leukemia, 10(3), 1996, pp. 456-459
ACUTE LYMPHOBLASTIC-LEUKEMIA FOLLOWING PRELEUKEMIC SYNDROMES IN ADULTS
Authors: ESCUDIER SM ALBITAR M ROBERTSON LE ANDREEFF M PIERCE S KANTARJIAN HM
Citation: Sm. Escudier et al., ACUTE LYMPHOBLASTIC-LEUKEMIA FOLLOWING PRELEUKEMIC SYNDROMES IN ADULTS, Leukemia, 10(3), 1996, pp. 473-477
NATURAL-KILLER-CELL ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTSTREATED WITH FLUDARABINE
Authors: ROBERTSON LE DENNY AW HUH YO PLUNKETT W KEATING MJ NELSON JA
Citation: Le. Robertson et al., NATURAL-KILLER-CELL ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTSTREATED WITH FLUDARABINE, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 445-450
SEQUENTIAL CISPLATINUM, FLUDARABINE, AND ARABINOSYL CYTOSINE (PFA) INPATIENTS WITH PRIOR FLUDARABINE THERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - A PHASE-II STUDY
Authors: GILES FJ OBRIEN S KANTARJIAN HM PLUNKETT W ESTEY E BERAN M YANG LY SEYMOUR J ROBERTSON LE LERNER S KEATING MJ
Citation: Fj. Giles et al., SEQUENTIAL CISPLATINUM, FLUDARABINE, AND ARABINOSYL CYTOSINE (PFA) INPATIENTS WITH PRIOR FLUDARABINE THERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - A PHASE-II STUDY, Blood, 88(10), 1996, pp. 3605-3605
SEQUENTIAL CISPLATINUM, FLUDARABINE, AND ARABINOSYL CYTOSINE (PFA) ORCYCLOPHOSPHAMIDE, FLUDARABINE AND ARABINOSYL CYTOSINE (CFA) IN PATIENTS WITH RICHTERS-SYNDROME (RS) - A PILOT-STUDY
Authors: GILES FJ OBRIEN S KANTARJIAN HM ESTEY E KOLLER C PLUNKETT W YANG LY SEYMOUR J ROBERTSON LE LERNER S KEATING MJ
Citation: Fj. Giles et al., SEQUENTIAL CISPLATINUM, FLUDARABINE, AND ARABINOSYL CYTOSINE (PFA) ORCYCLOPHOSPHAMIDE, FLUDARABINE AND ARABINOSYL CYTOSINE (CFA) IN PATIENTS WITH RICHTERS-SYNDROME (RS) - A PILOT-STUDY, Blood, 88(10), 1996, pp. 360-360
RESULTS OF INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA 60 YEARS OF AGE AND OLDER
Authors: CORTES J KANTARJIAN H OBRIEN S ROBERTSON LE PIERCE S TALPAZ M
Citation: J. Cortes et al., RESULTS OF INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA 60 YEARS OF AGE AND OLDER, The American journal of medicine, 100(4), 1996, pp. 452-455
HIGH-MOLECULAR-WEIGHT DNA FRAGMENTATION - A CRITICAL EVENT IN NUCLEOSIDE ANALOG-INDUCED APOPTOSIS IN LEUKEMIA-CELLS
Authors: HUANG P ROBERTSON LE WRIGHT S PLUNKETT W
Citation: P. Huang et al., HIGH-MOLECULAR-WEIGHT DNA FRAGMENTATION - A CRITICAL EVENT IN NUCLEOSIDE ANALOG-INDUCED APOPTOSIS IN LEUKEMIA-CELLS, Clinical cancer research, 1(9), 1995, pp. 1005-1013
IMPLICATIONS OF APOPTOTIC CELL-DEATH REGULATION IN CANCER-THERAPY
Authors: MCDONNELL TJ MEYN RE ROBERTSON LE
Citation: Tj. Mcdonnell et al., IMPLICATIONS OF APOPTOTIC CELL-DEATH REGULATION IN CANCER-THERAPY, Seminars in cancer biology, 6(1), 1995, pp. 53-60
SURVIVAL OF YOUNG-PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA FAILING FLUDARABINE THERAPY - A BASIS FOR THE USE OF MYELOABLATIVE THERAPIES
Authors: SEYMOUR JF ROBERTSON LE OBRIEN S LERNER S KEATING MJ
Citation: Jf. Seymour et al., SURVIVAL OF YOUNG-PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA FAILING FLUDARABINE THERAPY - A BASIS FOR THE USE OF MYELOABLATIVE THERAPIES, Leukemia & lymphoma, 18(5-6), 1995, pp. 493-496
IL-2 RECEPTOR EXPRESSION AND KI-67 FLOW CYTOMETRIC ANALYSIS IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: AYDIN A ELNAGGAR AK ROBERTSON LE KEATING MJ HUH YO
Citation: A. Aydin et al., IL-2 RECEPTOR EXPRESSION AND KI-67 FLOW CYTOMETRIC ANALYSIS IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA, International journal of oncology, 7(6), 1995, pp. 1433-1436
A 3-DAY SCHEDULE OF FLUDARABINE IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: ROBERTSON LE OBRIEN S KANTARJIAN H KOLLER C BERAN M ANDREEFF M LERNER S PLUNKETT W KEATING MJ
Citation: Le. Robertson et al., A 3-DAY SCHEDULE OF FLUDARABINE IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 9(9), 1995, pp. 1444-1449
FLUDARABINE PLUS DOXORUBICIN IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: ROBERTSON LE OBRIEN S KANTARJIAN H KOLLER C BERAN M ANDREEFF M LERNER S KEATING MJ
Citation: Le. Robertson et al., FLUDARABINE PLUS DOXORUBICIN IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 9(6), 1995, pp. 943-945
HOMOHARRINGTONINE THERAPY INDUCES RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN LATE CHRONIC PHASE
Authors: OBRIEN S KANTARJIAN H KEATING M BERAN M KOLLER C ROBERTSON LE HESTER J RIOS M ANDREEFF M TALPAZ M
Citation: S. Obrien et al., HOMOHARRINGTONINE THERAPY INDUCES RESPONSES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN LATE CHRONIC PHASE, Blood, 86(9), 1995, pp. 3322-3326
INTERFERON MAINTENANCE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA IN REMISSION AFTER FLUDARABINE THERAPY
Authors: OBRIEN S KANTARJIAN H BERAN M ROBERTSON LE KOLLER C LERNER S KEATING MJ
Citation: S. Obrien et al., INTERFERON MAINTENANCE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA IN REMISSION AFTER FLUDARABINE THERAPY, Blood, 86(4), 1995, pp. 1296-1300
2-CHLORODEOXYADENOSINE (2-CDA) THERAPY FOR IDIOPATHIC HYPEREOSINOPHILIC SYNDROME (HES)
Authors: UENO NT ZHAO S ROBERTSON LE CONSOLI U ANDREEFF M
Citation: Nt. Ueno et al., 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY FOR IDIOPATHIC HYPEREOSINOPHILIC SYNDROME (HES), Blood, 86(10), 1995, pp. 3198-3198
THE EXPANDING ROLE OF FLUDARABINE IN HEMATOLOGIC MALIGNANCIES
Authors: KEATING MJ OBRIEN S ROBERTSON LE KANTARJIAN H DIMOPOULOS M MCLAUGHLIN P CABANILLAS F GREGOIRE V YINGYANG L GANDHI V ESTEY E PLUNKETT W
Citation: Mj. Keating et al., THE EXPANDING ROLE OF FLUDARABINE IN HEMATOLOGIC MALIGNANCIES, Leukemia & lymphoma, 14, 1994, pp. 11-16
FLUDARABINE - PRESENT STATUS AND FUTURE-DEVELOPMENTS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND LYMPHOMA
Authors: KEATING MJ MCLAUGHLIN P PLUNKETT W ROBERTSON LE OBRIEN S GANDHI V GREGOIRE V YANG L CABANILLAS F
Citation: Mj. Keating et al., FLUDARABINE - PRESENT STATUS AND FUTURE-DEVELOPMENTS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND LYMPHOMA, Annals of oncology, 5, 1994, pp. 190000079-190000083
THERAPY-RELATED LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: ROBERTSON LE ESTEY E KANTARJIAN H KOLLER C OBRIEN S BROWN B KEATING MJ
Citation: Le. Robertson et al., THERAPY-RELATED LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 8(12), 1994, pp. 2047-2051
USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITHFLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: ESTEY E THALL P ANDREEFF M BERAN M KANTARJIAN H OBRIEN S ESCUDIER S ROBERTSON LE KOLLER C KORNBLAU S PIERCE S FREIREICH E DEISSEROTH A KEATING M
Citation: E. Estey et al., USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITHFLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 12(4), 1994, pp. 671-678
AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS
Authors: KHOURI IF KEATING MJ VRIESENDORP HM READING CL PRZEPIORKA D HUH YO ANDERSSON BS VANBESIEN KW MEHRA RC GIRALT SA IPPOLITI C MARSHALL M THOMAS MW OBRIEN S ROBERTSON LE DEISSEROTH AB CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758
COMBINATION OF FLUDARABINE AND ARABINOSYLCYTOSINE FOR TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL EFFICACY AND MODULATION OF ARABINOSYLCYTOSINE PHARMACOLOGY
Authors: GANDHI V ROBERTSON LE KEATING MJ PLUNKETT W
Citation: V. Gandhi et al., COMBINATION OF FLUDARABINE AND ARABINOSYLCYTOSINE FOR TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL EFFICACY AND MODULATION OF ARABINOSYLCYTOSINE PHARMACOLOGY, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 30-36
Risultati: 1-25 | 26-48